Schedule 13D ownership disclosure
ALX Oncology Holdings, Inc.
Security class unavailable · CUSIP: 00166B105
Event date: 2021-06-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,156,981
- Percent of class
- 7.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000389
- Form type
- SC 13D
- Filer
- ALX ONCOLOGY HOLDINGS INC
- CIK
- CIK 1810182
- Filed
- Jun 15, 2021
- Reporting period
- Jun 14, 2021
- Description
- Schedule 13D beneficial ownership